The European Medicines
Agency has posted an update on
development of its policy on public
access to clinical-trial data.
The public consultation on the
policy has generated more than
1,000 comments from stakeholders.
Further analysis of this input will
delay the finalisation of the policy
which was planned for Dec 2013.The above article was sent to subscribers in Pharmacy Daily's issue from 15 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Nov 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.